Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency

Ryan T. Fischer, Brian Friend, Geoffrey A Talmon, Wendy J. Grant, Ruben Quiros, Alan Norman Langnas, Peter F. Coccia

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

GVHD has been reported in 8-10% of children after small bowel transplant (SBTx). Immunodeficient children may be predisposed to aggressive, steroid-resistant GVHD. There exists a unique association of immunodeficiency in children with MIA (MIAI). We report on our SBTx experience in patients with the diagnosis of MIAI, their high incidence of GVHD, and the possible role of stem cell transplantation in these patients. We performed a review of records from children that underwent SBTx or that we evaluated for SBTx at our institution. We focused on the diagnoses of atresia, multiple intestinal atresia, immunodeficiency, and GVHD in our patient population. Children with MIAI are likely to experience severe GVHD following SBTx. MIAI correlated with a 100% incidence of GVHD in these patients. Of the five patients with MIAI that underwent SBTx, three succumbed to severe GVHD within 1-6 months after SBTx. One patient received stem cell transplant prior to SBTx and did not develop severe GVHD, but died from influenza nine months after SBTx. Our unique patient survives long-term, with engraftment of donor γ δ T cells. He has mild, persistent chronic GVHD. Atresia is a common referral diagnosis for SBTx. Patients with multiple atresias, especially MIAI, are at significant risk for the complication of GVHD following SBTx. We recommend careful immunologic assessment and antecedent stem cell transplant in children with MIAI prior to SBTx.

Original languageEnglish (US)
Pages (from-to)190-196
Number of pages7
JournalPediatric Transplantation
Volume18
Issue number2
DOIs
StatePublished - Mar 1 2014

Fingerprint

Transplantation
Transplants
Stem Cells
Multiple Intestinal Atresia
Incidence
Stem Cell Transplantation
Human Influenza
Referral and Consultation
Steroids
Tissue Donors
T-Lymphocytes
Population

Keywords

  • graft-versus-host disease
  • immunodeficiency
  • intestinal transplantation
  • multiple intestinal atresia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency. / Fischer, Ryan T.; Friend, Brian; Talmon, Geoffrey A; Grant, Wendy J.; Quiros, Ruben; Langnas, Alan Norman; Coccia, Peter F.

In: Pediatric Transplantation, Vol. 18, No. 2, 01.03.2014, p. 190-196.

Research output: Contribution to journalArticle

@article{abe2ae24266c4d6bb504f2e3389799ec,
title = "Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency",
abstract = "GVHD has been reported in 8-10{\%} of children after small bowel transplant (SBTx). Immunodeficient children may be predisposed to aggressive, steroid-resistant GVHD. There exists a unique association of immunodeficiency in children with MIA (MIAI). We report on our SBTx experience in patients with the diagnosis of MIAI, their high incidence of GVHD, and the possible role of stem cell transplantation in these patients. We performed a review of records from children that underwent SBTx or that we evaluated for SBTx at our institution. We focused on the diagnoses of atresia, multiple intestinal atresia, immunodeficiency, and GVHD in our patient population. Children with MIAI are likely to experience severe GVHD following SBTx. MIAI correlated with a 100{\%} incidence of GVHD in these patients. Of the five patients with MIAI that underwent SBTx, three succumbed to severe GVHD within 1-6 months after SBTx. One patient received stem cell transplant prior to SBTx and did not develop severe GVHD, but died from influenza nine months after SBTx. Our unique patient survives long-term, with engraftment of donor γ δ T cells. He has mild, persistent chronic GVHD. Atresia is a common referral diagnosis for SBTx. Patients with multiple atresias, especially MIAI, are at significant risk for the complication of GVHD following SBTx. We recommend careful immunologic assessment and antecedent stem cell transplant in children with MIAI prior to SBTx.",
keywords = "graft-versus-host disease, immunodeficiency, intestinal transplantation, multiple intestinal atresia",
author = "Fischer, {Ryan T.} and Brian Friend and Talmon, {Geoffrey A} and Grant, {Wendy J.} and Ruben Quiros and Langnas, {Alan Norman} and Coccia, {Peter F.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1111/petr.12211",
language = "English (US)",
volume = "18",
pages = "190--196",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency

AU - Fischer, Ryan T.

AU - Friend, Brian

AU - Talmon, Geoffrey A

AU - Grant, Wendy J.

AU - Quiros, Ruben

AU - Langnas, Alan Norman

AU - Coccia, Peter F.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - GVHD has been reported in 8-10% of children after small bowel transplant (SBTx). Immunodeficient children may be predisposed to aggressive, steroid-resistant GVHD. There exists a unique association of immunodeficiency in children with MIA (MIAI). We report on our SBTx experience in patients with the diagnosis of MIAI, their high incidence of GVHD, and the possible role of stem cell transplantation in these patients. We performed a review of records from children that underwent SBTx or that we evaluated for SBTx at our institution. We focused on the diagnoses of atresia, multiple intestinal atresia, immunodeficiency, and GVHD in our patient population. Children with MIAI are likely to experience severe GVHD following SBTx. MIAI correlated with a 100% incidence of GVHD in these patients. Of the five patients with MIAI that underwent SBTx, three succumbed to severe GVHD within 1-6 months after SBTx. One patient received stem cell transplant prior to SBTx and did not develop severe GVHD, but died from influenza nine months after SBTx. Our unique patient survives long-term, with engraftment of donor γ δ T cells. He has mild, persistent chronic GVHD. Atresia is a common referral diagnosis for SBTx. Patients with multiple atresias, especially MIAI, are at significant risk for the complication of GVHD following SBTx. We recommend careful immunologic assessment and antecedent stem cell transplant in children with MIAI prior to SBTx.

AB - GVHD has been reported in 8-10% of children after small bowel transplant (SBTx). Immunodeficient children may be predisposed to aggressive, steroid-resistant GVHD. There exists a unique association of immunodeficiency in children with MIA (MIAI). We report on our SBTx experience in patients with the diagnosis of MIAI, their high incidence of GVHD, and the possible role of stem cell transplantation in these patients. We performed a review of records from children that underwent SBTx or that we evaluated for SBTx at our institution. We focused on the diagnoses of atresia, multiple intestinal atresia, immunodeficiency, and GVHD in our patient population. Children with MIAI are likely to experience severe GVHD following SBTx. MIAI correlated with a 100% incidence of GVHD in these patients. Of the five patients with MIAI that underwent SBTx, three succumbed to severe GVHD within 1-6 months after SBTx. One patient received stem cell transplant prior to SBTx and did not develop severe GVHD, but died from influenza nine months after SBTx. Our unique patient survives long-term, with engraftment of donor γ δ T cells. He has mild, persistent chronic GVHD. Atresia is a common referral diagnosis for SBTx. Patients with multiple atresias, especially MIAI, are at significant risk for the complication of GVHD following SBTx. We recommend careful immunologic assessment and antecedent stem cell transplant in children with MIAI prior to SBTx.

KW - graft-versus-host disease

KW - immunodeficiency

KW - intestinal transplantation

KW - multiple intestinal atresia

UR - http://www.scopus.com/inward/record.url?scp=84893825449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893825449&partnerID=8YFLogxK

U2 - 10.1111/petr.12211

DO - 10.1111/petr.12211

M3 - Article

C2 - 24373162

AN - SCOPUS:84893825449

VL - 18

SP - 190

EP - 196

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 2

ER -